1238 / 1332
GUSTAVE ROUSSY
THÈME DU DIAPORAMA
RetroEMBRACE outcome data
Primary Objective: Local control in IGABT within
multi-institutional frame prior to EMBRACE study
12 institutions participating January 1998 - August 2012
852 patients included, 49 excluded for unknown disease
status and 72 excluded due to adjuvant therapy, 731
analyzed
2 IA (0.3%), 123 IB (16.8%), 42 IIA (5.7%), 368 IIB (50.3%),
23 IIIA (3.1%), 145 IIIB (19.8%), 23 stage IVA (3.1%), 5 IVB
(0.7%)
Median width at diagnosis: 50 mm clinical, 46 mm at MRI
examination
Nodal status : N+ 40%, N- 60%
Sturdza Radiother Oncol 2016;120:428-33